50 /100
MEDIUM RISK
Score updated Jul 14, 2026

ITRM — Iterum Therapeutics PLC Dilution Risk Tracker

Track ITRM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ITRM — Get alerts when the score changes →

As of July 14, 2026, Iterum Therapeutics PLC (ITRM) has a DilutionWatch DilutionScore of 50/100, rated MEDIUM dilution risk. Iterum Therapeutics PLC has a market capitalization of $1.60M, 44.66M shares outstanding, 18 institutional holders tracked. Key dilution vectors include 25.3K outstanding warrants, approximately 4 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
85
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
45%
🔄 Reverse Split 70%
• 50-day avg $0.21 below $1 exchange minimum
• Only 4 months cash — financial pressure
💰 Capital Raise 35%
• Low cash runway: 4 months remaining
🔔 Track ITRM — Get forecast alerts →

💹 Market Data

Market Cap$1.60M
Shares Outstanding44.66M
FloatN/A
Cash$11.00M
Debt$13.08M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 5.6% shares (2026Q1 vs prior)
18 institutional holders · 1.44M shares
#1 HRT FINANCIAL LP 890.1K shares
#2 CAPTRUST FINANCIAL ADVISORS 138.6K shares
#3 Gen-Wealth Partners Inc 82.6K shares
+ 15 more holders Sign up free to view →

📉 Short Interest

Short Interest9.35M
Days to Cover1.0
% of FloatN/A
FINRA data as of Mar 31, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Apr 28, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2023
Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for ITRM Shareholders

Iterum Therapeutics PLC (ITRM) has a DilutionScore of 50/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

Cash runway is a key watch item: ITRM has approximately 4 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for ITRM in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for ITRM alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track ITRM Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ITRM — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

AAT ACH AHRT ALOT AMPH

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for ITRM
📊 ITRM FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ITRM Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.